Online Pharmacy Regulatory Gap, Public Protection Benefits of .Pharmacy Domain Name Highlighted in Report on Drug Supply Chain Security
NABP’s .pharmacy Top-Level Domain (TLD) and its goal of providing a reliable resource for consumers to identify safe and legitimate online pharmacies and related websites were highlighted in the 2015 Product Security Report from Pharmaceutical Commerce; however, concerns about illegal online drug seller activity remain. In addition, the report outlines the efforts of manufacturers and […]
Read More ›General Availability for .Pharmacy Domain Names Begins June 3, 2015
NABP is pleased to announce that general availability for the .pharmacy domain begins June 3, 2015. At this time, all pharmacies and pharmacy-related entities may apply for .pharmacy domain names. The .pharmacy Top-Level Domain (TLD) was launched in 2014, and NABP has approved more than 300 .pharmacy domain names applied for or requested during prior […]
Read More ›Potentially Lethal Drug Sold Globally as Diet Supplement, Warns INTERPOL
INTERPOL has issued a global alert for a drug known as 2.4-dinitrophenol (DNP), an illicit and potentially lethal drug sold as a dieting and body-building aid. The “Orange Notice” (PDF) warning about DNP was published after a woman in the United Kingdom died and a man in France was left seriously ill after taking the substance. […]
Read More ›FDA Submits Proposal to Collect Information Regarding the Impact of Physical Differences in Generic Drug Pills on Medication Adherence
Food and Drug Administration (FDA) has proposed a series of surveys to gather information on patient awareness about changes in the appearance of their medications, how often the change in appearance occurs, and what strategies pharmacists use to inform patients when these changes occur. The survey results will be used to inform the development of […]
Read More ›Rogue Internet Drug Sellers Scrutinized at Congressional Committee Hearing on Internet Accountability
The United States House of Representatives Judiciary Subcommittee on Courts, Intellectual Property, and the Internet held a hearing today, May 13, 2015, to hear testimony from stakeholders regarding the Internet Corporation for Assigned Names and Numbers, how the Internet is governed, and steps for trust and accountability in the Internet’s operation. As part of the […]
Read More ›USP Invites Compounding Facilities to Participate in 2015 USP Chapter Compliance Study
Sterile compounding practices are invited to participate in the 2015 United States Pharmacopeia (USP) <797> Compliance Study. The study, the largest and most comprehensive study of USP compliance, will remain open until June 30, 2015. The 2015 USP <797> Compliance Study uses a sophisticated, web-based <797> Gap Analysis Tool developed by Kate Douglass, MS, RN, […]
Read More ›ADHD Stimulant Abuse Growing Among US Workers, The New York Times Reports
Though commonly associated with college students, abuse of prescription stimulants intended to treat attention deficit hyperactivity disorder (ADHD) is a growing phenomenon among American workers. While there is no authoritative data on this emerging trend, the article cites dozens of interviews with workers “in a wide spectrum of professions” who say they or coworkers abuse […]
Read More ›Synthetic Cannabinoid Hospitalizations Surge in Alabama, Mississippi, and Other States
From March 15 through April 20, 462 people in Alabama were sent to a hospital emergency department, and 473 people in Mississippi were hospitalized due to synthetic cannabinoid overdoses, according to CBS News. The drug, also known as “K2” and “Spice” sickened more than 160 people in New York, and may be tied to the […]
Read More ›Outbreak of HIV and HCV Infections in Indiana Prompts CDC Health Alert
Centers for Disease Control and Prevention (CDC) has issued an official health advisory alerting health care providers to an outbreak of human immunodeficiency virus (HIV) and hepatitis C (HCV) among persons who inject drugs in a rural portion of Indiana. An ongoing investigation by the Indiana State Department of Health with assistance from CDC has […]
Read More ›Opioid Dispensing and Prescription Overdose Decreased Substantially After Introduction of Abuse-Deterrent Formulation, Study Reports
Overdoses and overall prevalence of opioid prescription painkillers has decreased since abuse-deterrent extended-release oxycodone hydrochloride was introduced and propoxyphene was withdrawn from the United States market, a study published in JAMA Internal Medicinehas found. The study, “Rates of Opioid Dispensing and Overdose After Introduction of Abuse-Deterrent Extended-Release Oxycodone and Withdrawal of Propoxyphene,” found that the […]
Read More ›